Bioequivalence and Bioavailability Forum

Main page Policy/Terms of Use Abbreviations Latest Posts

 Log in |  Register |  Search

Back to the forum  2018-07-23 00:08 CEST (UTC+2h)

Levothyroxine Sample size and study design [Power / Sample Size]

posted by jag009 - NJ, 2018-04-12 22:47  - Posting: # 18673
Views: 867

Hi,
1) How old are the literatures? Crossover studies probably were done before drug was considered under the NTI assessment rules.
2) Are you filing FDA or elsewhere?
3) Are you going to run pilot studies?
J

Complete thread:

Back to the forum Activity
 Mix view
Bioequivalence and Bioavailability Forum |  Admin contact
18,547 posts in 3,941 threads, 1,190 registered users;
online 15 (0 registered, 15 guests [including 14 identified bots]).

[The] impatience with ambiguity can be criticized in the phrase:
absence of evidence is not evidence of absence.    Carl Sagan

The BIOEQUIVALENCE / BIOAVAILABILITY FORUM is hosted by
BEBAC Ing. Helmut Schütz
HTML5 RSS Feed